DrugPatentWatch Database Preview
Litigation Details for H. Lundbeck A/S v. Lupin Limited (D. Del. 2018)
» See Plans and Pricing
H. Lundbeck A/S v. Lupin Limited (D. Del. 2018)
| Docket | Start Trial | Date Filed | 2018-01-11 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Defendant | Referred To | |
| Parties | ZYDUS PHARMACEUTICALS (USA) INC. | ||
| Patents | 7,144,884; 8,476,279; 8,722,684; 8,969,355; 9,125,908; 9,125,909; 9,125,910; 9,227,946; 9,278,096; 9,861,630 | ||
| Attorneys | Kenneth Laurence Dorsney | ||
| Firms | Connolly Gallagher LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in H. Lundbeck A/S v. Lupin Limited
The small molecule drug covered by the patents cited in this case is Start Trial .
Details for H. Lundbeck A/S v. Lupin Limited (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-03-27 | 15 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,861,630 B1; . (Noreika, Maryellen… 12 January 2018 1:18-cv-00088 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document | |
| 2019-05-14 | 250 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,722,684 B2 ;8,969,355 B2 ;9,227,946… 12 January 2018 1:18-cv-00088 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| 2019-05-31 | 280 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,144,884 ;8,476,279 ;8,722,684… 12 January 2018 1:18-cv-00088 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| 2018-07-09 | 31 | Scheduling Order - Patent | allegation of infringement of United States Patent Nos. 7,144,884, 8,476,279, 8,722,684 8,969,355, 9,227,946…asserted patents it alleges are infringed and produce the file history for each asserted patent, pursuant…Identification of Accused Products and Asserted Patents. By July 13, 2018, Plaintiffs shall identify…invalidating references (e.g., publications, manuals, and patents), pursuant to D. Del. Default Standard Paragraph…same issue for more than one of the asserted patents shall count as one Interrogatory. An Interrogatory | External link to document |
| 2019-06-14 | 312 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,125,908 B2 ;9,125,909 B2 . … 12 January 2018 1:18-cv-00088 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| 2019-07-05 | 337 | Redacted Document | Nos. 8,722,684 (“the ’684 Patent”); 8,969,355 (“the ’355 Patent”); 9,227,946 (“the ’946 Patent”); and… United States Patent Nos. 8,722,684 (“the ’684 patent”), 8,969,355 (“the ’355 patent”), 9,227,946 (… (“the ’946 patent”), 9,861,630 (“the ’630 patent”), 9,125,910 (“the ’910 patent”), and 9,278,096 (“… (INVALIDITY OF THE ’910 PATENT) The claims of the ’910 patent are invalid and/or unenforceable… (INVALIDITY OF THE ’096 PATENT) The claims of the ’096 patent are invalid and/or unenforceable | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
